Galantamine slowed decline in cognitive function, functional ability, and behavior at 6 months in people with Alzheimer's ...
A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.
Research shows frailty levels rise significantly before dementia, suggesting it could be a key marker for early ...